QDEL.NASDAQQuidelortho CORP

Form 4: QuidelOrtho Executive Ronald Lee Bowman Acquires Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Ronald Lee Bowman, Chief Human Resources Officer at QuidelOrtho, acquired 8,816 restricted stock units and 8,815 non-qualified stock options on January 29, 2025.

Summary

  • Ronald Lee Bowman, the Chief Human Resources Officer of QuidelOrtho Corp, has reported the acquisition of 8,816 restricted stock units and 8,815 non-qualified stock options.
  • The restricted stock units will vest over three years, with 2,938 shares vesting on January 29, 2026, and the remaining 5,878 shares vesting in equal installments on January 29, 2027 and January 29, 2028.
  • The non-qualified stock options will also vest over three years, with 5,876 shares vesting in equal installments on January 29, 2026 and January 29, 2027, and the remaining 2,939 shares vesting on January 29, 2028.
  • The exercise price for the non-qualified stock options is $43.52.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively as it aligns management interests with shareholders. There is no indication of any negative sentiment.

Positives

  • The acquisition of stock options and restricted stock units by a key executive suggests confidence in the company's future performance.
  • The vesting schedule of the stock options and restricted stock units encourages long-term commitment from the executive.

Industry Context

This is a standard practice for public companies to incentivize and retain key executives through equity-based compensation.

Comparison to Industry Standards

  • Equity-based compensation, such as stock options and restricted stock units, is a common practice among publicly traded companies like QuidelOrtho.
  • Companies such as Abbott Laboratories, Danaher Corporation, and Thermo Fisher Scientific also use similar compensation methods to align executive interests with shareholder value.
  • The vesting schedules described are typical for these types of grants, encouraging long-term performance and retention.

Stakeholder Impact

  • The acquisition of stock options and restricted stock units by a key executive can be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
  • Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
01/29/2025Date of the transaction where Ronald Lee Bowman acquired restricted stock units and non-qualified stock options.
01/29/2026First vesting date for a portion of the restricted stock units and non-qualified stock options.
01/29/2027Second vesting date for a portion of the restricted stock units and non-qualified stock options.
01/29/2028Final vesting date for the remaining restricted stock units and non-qualified stock options.
01/31/2025Date the Form 4 was signed.

Keywords

QuidelOrtho, stock options, restricted stock units, insider trading, executive compensation, Form 4, Ronald Lee Bowman

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.